The following table provides an overview of the latest patents of Esteve Pharmaceuticals, S.a. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP2817000Aug 4, 2021Oral Pharmaceutical Compositions Of Dabigatran Etexilate3